Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
CBIO
— Crescent Biopharma, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2024 Earnings Call Summary
MAY 6, 2024
REVENUE
$0
-100.0%
EPS
-$16.66
-18.2%
FREE CASH FLOW
-$10.5M
-38.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →